Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Cancers”

1,044 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,044 results

Early research (Phase 1)Looking for participantsNCT06564623
What this trial is testing

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Who this might be right for
Biliary Tract Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Study completedNCT05052099
What this trial is testing

Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
University Hospital, Essen 20
Testing effectiveness (Phase 2)UnknownNCT03943043
What this trial is testing

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Who this might be right for
Cholangiocarcinoma
Istituto Clinico Humanitas 85
Not applicableStudy completedNCT02692911
What this trial is testing

Chile Biliary Longitudinal Study

Who this might be right for
Gallbladder CancerNutritional and Metabolic Diseases
National Cancer Institute (NCI) 4,749
Testing effectiveness (Phase 2)UnknownNCT03603834
What this trial is testing

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Khon Kaen University 25
Not applicableUnknownNCT02809898
What this trial is testing

The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
RenJi Hospital 30
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT03406299
What this trial is testing

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
National Health Research Institutes, Taiwan 92
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Early research (Phase 1)Study completedNCT05712889
What this trial is testing

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 29
Not applicableEnded earlyNCT02900248
What this trial is testing

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

Who this might be right for
NeoplasmsLung NeoplasmsColon Neoplasms+22 more
CureOne 23
Not applicableStudy completedNCT04595058
What this trial is testing

LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent

Who this might be right for
Biliary ObstructionPancreatic CancerBiliary Tract Neoplasms
Hospital Universitari de Bellvitge 123
Testing effectiveness (Phase 2)Ended earlyNCT04566133
What this trial is testing

Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).

Who this might be right for
Bile Duct CancerBiliary CancerBiliary Tract Neoplasms+1 more
National Cancer Institute (NCI) 2
Not applicableNot Yet RecruitingNCT06670547
What this trial is testing

Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Who this might be right for
CholedocholithiasisCholedocholithiasis With Acute CholangitisCholangiocarcinoma+4 more
Germans Trias i Pujol Hospital 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT06708858
What this trial is testing

Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Dai, Guanghai 35
Testing effectiveness (Phase 2)Looking for participantsNCT06001658
What this trial is testing

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

Who this might be right for
Billiary Track Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)UnknownNCT03772132
What this trial is testing

Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctGallbladder Cancer
Shanghai Jiao Tong University School of Medicine 100
Not applicableStudy completedNCT04572711
What this trial is testing

Prospective Evaluation of Biliary Tissue Sampling With ERCP

Who this might be right for
Cholangiopancreatography, Endoscopic RetrogradeBiliary StrictureBiliary Tract Diseases+1 more
Mayo Clinic 327
Not applicableStudy completedNCT02088775
What this trial is testing

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct Cancer+4 more
Fox Chase Cancer Center 44
Not applicableStudy completedNCT02670265
What this trial is testing

Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions

Who this might be right for
Weight LossPancreatic CancerBiliary Tract Cancer
University Medicine Greifswald 100
Load More Results